A process analytical technology approach based on near infrared spectroscopy:: Tablet hardness, content uniformity, and dissolution test measurements of intact tablets

被引:103
作者
Blanco, Marcelo [1 ]
Alcala, Manel
Gonzalez, Josep M.
Torrasz, Ester
机构
[1] Univ Autonoma Barcelona, Dept Chem, Analyt Chem Unit, Fac Sci, E-08193 Barcelona, Spain
[2] Lab Menarini SA, E-08918 Barcelona, Spain
关键词
near infrared spectroscopy; pharmaceuticals; intact tablets; partial least squares; discriminant partial least squares; content uniformity; compaction; dissolution; process analytical technology;
D O I
10.1002/jps.20653
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Near infrared spectroscopy (NIRS) is a nondestructive analytical technique that enables simultaneous measurements of chemical composition (viz. the content in active pharmaceutical ingredient, API) and various physical properties (viz. tablet hardness and dissolution profile) in pharmaceutical tablets. In this work, partial least squares (PLS) calibration models and discriminant partial least squares (DPLS) classification models were constructed by using calibration sets consisting of laboratory samples alone. The laboratory samples were mixtures of the API and excipients that were pressed into tablets. API content, tablet hardness, and dissolution measurements of intact tablets were made by using three different calibration models that are fast-results can be obtained within a few seconds-,simple and robust-they involve minimal analyst intervention-, and clean-they use no toxic reagent and produce no toxic waste. Based on the results, the proposed NIR method is an effective alternative to current reference methods for the intended purpose. The advantages provided by NIR spectroscopy in this context confirm its potential for inclusion in process analytical technologies in the pharmaceutical industry. (c) 2006 Wiley-Liss, Inc.
引用
收藏
页码:2137 / 2144
页数:8
相关论文
共 12 条
[1]   Simultaneous quantitation of five active principles in a pharmaceutical preparation:: Development and validation of a near infrared spectroscopic method [J].
Blanco, M ;
Alcalá, M .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2006, 27 (2-3) :280-286
[2]   Content uniformity and tablet hardness testing of intact pharmaceutical tablets by near infrared spectroscopy -: A contribution to process analytical technologies [J].
Blanco, M ;
Alcalá, M .
ANALYTICA CHIMICA ACTA, 2006, 557 (1-2) :353-359
[3]   Near-infrared determination of active substance content in intact low-dosage tablets [J].
Chalus, P ;
Roggo, Y ;
Walter, S ;
Ulmschneider, M .
TALANTA, 2005, 66 (05) :1294-1302
[4]  
COLON J, 2005, J P ANAL TECH, V2, P8
[5]   Prediction of tablets disintegration times using near-infrared diffuse reflectance spectroscopy as a nondestructive method [J].
Donoso, M ;
Ghaly, ES .
PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY, 2005, 10 (02) :211-217
[6]   Prediction of drug dissolution profiles from tablets using NIR diffuse reflectance spectroscopy: A rapid and nondestructive method [J].
Freitas, MP ;
Sabadin, A ;
Silva, LM ;
Giannotti, FM ;
do Couto, DA ;
Tonhi, E ;
Medeiros, RS ;
Coco, GL ;
Russo, VFT ;
Martins, JA .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2005, 39 (1-2) :17-21
[7]   Real-time near-infrared monitoring of content uniformity, moisture content, compact density, tensile strength, and Young's modulus of roller compacted powder blends [J].
Gupta, A ;
Peck, GE ;
Miller, RW ;
Morris, KR .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2005, 94 (07) :1589-1597
[8]   Low-temperature inhibition of the activated sludge process by an industrial discharge containing the azo dye acid black 1 [J].
Martin, RW ;
Baillod, CR ;
Mihelcic, JR .
WATER RESEARCH, 2005, 39 (01) :17-28
[9]   A compaction process to enhance dissolution of poorly watersoluble drugs using hydroxypropyl methylcellulose [J].
Mitchell, SA ;
Reynolds, TD ;
Dasbach, TP .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2003, 250 (01) :3-11
[10]   Investigation of the effect of tablet surface area/volume on drug release from hydroxypropylmethylcellulose controlled-release matrix tablets [J].
Reynolds, TD ;
Mitchell, SA ;
Balwinski, KM .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2002, 28 (04) :457-466